Real Peptides GLP-2

Description

Tirzepatide is a synthetic peptide research compound characterized as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It has been studied in preclinical research as a tool compound for isolating incretin signaling endpoints in metabolic experimental designs.

Tirzepatide has been examined in preclinical in vitro and rodent model studies of glucose homeostasis, insulin secretion dynamics, appetite-related behavioral paradigms, and dual receptor signaling. Its combined receptor activity supports comparative mechanistic studies of incretin biology in cell-based and rodent research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.